Suzhou Medsys Tech Co Ltd (SHG:603990) — Market Cap & Net Worth
Market Cap & Net Worth: Suzhou Medsys Tech Co Ltd (603990)
Suzhou Medsys Tech Co Ltd (SHG:603990) has a market capitalization of $813.01 Million (CN¥5.56 Billion) as of August 4, 2026. Listed on the SHG stock exchange, this China-based company holds position #9653 globally and #2436 in its home market, demonstrating a 5.77% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Suzhou Medsys Tech Co Ltd's stock price CN¥18.14 by its total outstanding shares 306282731 (306.28 Million). See 603990 capex to operating cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Suzhou Medsys Tech Co Ltd Market Cap History: 2016 to 2026
Suzhou Medsys Tech Co Ltd's market capitalization history from 2016 to 2026. Data shows change from $784.32 Million to $813.01 Million (-35.35% CAGR).
Suzhou Medsys Tech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Suzhou Medsys Tech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.99x
Suzhou Medsys Tech Co Ltd's market cap is 0.99 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $784.32 Million | $240.64 Million | $45.21 Million | 3.26x | 17.35x |
| 2017 | $513.39 Million | $268.68 Million | $51.11 Million | 1.91x | 10.04x |
| 2018 | $472.48 Million | $284.28 Million | $55.48 Million | 1.66x | 8.52x |
| 2019 | $703.75 Million | $333.12 Million | $46.89 Million | 2.11x | 15.01x |
| 2020 | $849.86 Million | $308.08 Million | $35.44 Million | 2.76x | 23.98x |
| 2021 | $590.86 Million | $353.85 Million | $41.95 Million | 1.67x | 14.08x |
| 2022 | $657.46 Million | $305.51 Million | $33.56 Million | 2.15x | 19.59x |
| 2023 | $579.06 Million | $618.14 Million | -$269.42 Million | 0.94x | N/A |
| 2024 | $460.74 Million | $464.07 Million | -$279.47 Million | 0.99x | N/A |
Competitor Companies of 603990 by Market Capitalization
Companies near Suzhou Medsys Tech Co Ltd in the global market cap rankings as of August 4, 2026.
Key companies related to Suzhou Medsys Tech Co Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #980 globally with a market cap of $27.24 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1930 globally with a market cap of $11.99 Billion USD ( AU$16.95 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2122 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2674 globally with a market cap of $7.62 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #980 | Veeva Systems Inc Class A | NYSE:VEEV | $27.24 Billion | $203.78 |
| #1930 | Pro Medicus Ltd | AU:PME | $11.99 Billion | AU$162.21 |
| #2122 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $59.71 |
| #2674 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $7.62 Billion | $43.87 |
Suzhou Medsys Tech Co Ltd Historical Marketcap From 2016 to 2026
Between 2016 and today, Suzhou Medsys Tech Co Ltd's market cap moved from $784.32 Million to $ 813.01 Million, with a yearly change of -35.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥813.01 Million | +19.58% |
| 2025 | CN¥679.90 Million | +47.57% |
| 2024 | CN¥460.74 Million | -20.43% |
| 2023 | CN¥579.06 Million | -11.92% |
| 2022 | CN¥657.46 Million | +11.27% |
| 2021 | CN¥590.86 Million | -30.48% |
| 2020 | CN¥849.86 Million | +20.76% |
| 2019 | CN¥703.75 Million | +48.95% |
| 2018 | CN¥472.48 Million | -7.97% |
| 2017 | CN¥513.39 Million | -34.54% |
| 2016 | CN¥784.32 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Suzhou Medsys Tech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $813.01 Million USD |
| MoneyControl | $813.01 Million USD |
| MarketWatch | $813.01 Million USD |
| marketcap.company | $813.01 Million USD |
| Reuters | $813.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Suzhou Medsys Tech Co Ltd
Suzhou MedicalSystem Technology Co., Ltd. provides solutions in clinical informatics and digital hospital field in China. It offers DoCare anesthesia clinical information system that focuses on serving the perioperative clinical work; and provides streamlined, informational, automatic, and intelligent integrated management platform for clinical business. The company also provides DoCare intensive… Read more